enVVeno Medical Corporation - fluxo de caixa trimestral (NASDAQ:NVNO) | MetaTrader

Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas

Cash from operating activities -5.11 M-4.02 M-3.71 M-4.39 M-3.44 M -15.57 M Cash from investing activities -11.06 M5.2 M2.82 M3.65 M4.18 M 15.86 M Cash from financing activities 000241 K782 K 1.02 M Free cash flow -5.11 M-4.02 M-3.72 M-4.39 M-3.44 M -15.57 M

Notícias

enVVeno Medical recupera conformidade com a Nasdaq e reporta US$ 28 milhões em caixa

enVVeno Medical regains Nasdaq compliance, reports $28 million cash

enVVeno Medical announces 1-for-35 reverse stock split

enVVeno Medical atualiza estatutos para revisar requisito de quórum de acionistas

enVVeno Medical updates bylaws to revise stockholder quorum requirement

Ações da enVVeno Medical despencam após FDA manter rejeição da VenoValve

enVVeno Medical stock plunges after FDA upholds rejection of VenoValve

Gold Tumbles Over 2%; Cidara Therapeutics Shares Spike Higher - Amaze Holdings (AMEX:AMZE), Cidara Therapeutics (NASDAQ:CDTX)

Nasdaq Dips Over 300 Points; Applied Materials Posts Upbeat Q4 Earnings - Applied Mat (NASDAQ:AMAT), Amaze Holdings (AMEX:AMZE)

Why RLX Technology Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket - Binah Capital Group (NASDAQ:BCG), Aspire Biopharma Hldgs (NASDAQ:ASBP)

FDA rejeita recurso da enVVeno Medical para aprovação da VenoValve

FDA rejects enVVeno Medical’s appeal for VenoValve approval